Scientific Findings: Cancer and Skin Toxicity
San Francisco, CA (UCSF Department of Dermatology – Original Article) April 20th, 2009
Abstract: As inhibitors of the epidermal growth factor receptor (EGFR) become an increasingly common therapeutic option in cancer, appropriate management of their associated toxicities emerges as a critical part of treatment. Cutaneous manifestations, probably linked to the function of the EGFR in epithelial development, are the most common adverse reactions to EGFR inhibition. The key manifestations are follicular eruptions, nail disorders, xerosis, and desquamation. Growing attention continues to be devoted to the analysis of these events, particularly given their potential role as markers of responsiveness to treatment. However, to date, there are few evidence-based guidelines for the appropriate management of these dermatologic events. Multidisciplinary collaboration between oncologists and dermatologists will be required to improve our understanding and optimize the characterization of these skin toxicities, and to design effective management approaches. Read More
published April 20th, 2006
Also in News
Gifts for Someone Going Through Chemo: A Caregiver's Guide (2026)
Practical, comforting gift ideas for someone going through chemo, from soft socks and meal help to gentle skin care.
What to Put in a Chemo Care Package: A Skin-Care Checklist
A practical chemo care package checklist: gentle skin care, treatment-day comforts and rest items, with tips from the National Cancer Institute (NCI).